
Molteni Farmaceutici Polskasp. z o.o.
Other professional, scientific and technical activities not elsewhere classified
Overview
Molteni Farmaceutici Polska produces and supplies medicines used in pain treatment, anesthesia, addiction therapy and diabetes control. Founded in Krakow in 1994, it was the first foreign investment of the Italian company L. Molteni & C. dei F.lli Alitti, which has operated since 1892.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 101 days early.
- 202531/03/2026
- 202424/03/2025
- 202323/05/2024
- 202231/03/2023
- 202105/05/2022
- 202012/05/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
- Research and experimental development in natural sciences and engineering (72.1)
Trademarks
Molteni Farmaceutici Polska holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2009.
| Mark | Protected until | |
|---|---|---|
| bunorfin(word) | Feb 23, 2029 |
Authorized Representatives
Manner of representation
The President of the Management Board is authorized to make declarations of will and sign on behalf of the company independently, while the Vice-President or another member of the management board is authorized jointly with the President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
L.molteni & C. Dei Fratelli Alitti Societa Di Esercizio - S.A. | 27,280 | $368,449.49 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1994-12-14.
03 1500 1142 1211 4007 9076 0000
27 1500 1142 1211 4000 6375 0000
26 1090 1665 0000 0001 6536 9614
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 9,695PLN 9,695 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $16,768$16,768 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $11,346$11,346 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,937$9,937 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Jagiellońskie Centrum Innowacjisp. z o.o. | $10,019,041.09 | jagiellonskiecentruminnowacji.pl | ||
| Innoenergy Central Europesp. z o.o. | $4,446,848.57 | innoenergy.com | ||
| SG Marketingsp. z o.o. | $2,784,071.36 | sgmarketing.pl | ||
| SHM Systemsp. z o.o. + limited partnership | $2,768,011.84 | web.archive.org | ||
| Grupa 2.0sp. z o.o. | $2,741,572.61 | bliski.com.pl | ||
| Scope Ratings GmbhBranch (foreign co.) | $2,606,060.15 | scoperatings.com | ||
| Biocert Małopolskasp. z o.o. | $2,237,395.69 | biocert.pl | ||
| Autodiscover Importsp. z o.o. | $1,356,197.64 | autodiscover.pl | ||
| Gusstechsp. z o.o. | $1,128,409.35 | gusstech.com | ||
| Ekoradcysp. z o.o. | $844,277.85 | ekoradcy.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-02-11 | Address change (Obrońców Modlina 3, 30-733, Kraków → Ul. Józefa Korzeniowskiego 39, 30-214, Kraków) | |
| 2018-12-14 | PKD change (Removed: 25 codes) | |
| 2010-08-10 | Switch to PKD 2007 (6 PKD 2004 codes → 34 PKD 2007 codes) | |
| 2004-05-12 | Address change (Obrońców Modlina 3, 30-833, Kraków → Obrońców Modlina 3, 30-733, Kraków) | |
| 2004-01-30 | Entered in the register |
FAQ
Last updated: 2026-10-07